Citation 38664

WANG,JD: NARUI,T: TAKATSUKI,S: HASHIMOTO,T: KOBAYASHI,F: EKIMOTO,H: ABUKI,H: NIJIMA,K: OKUYAMA,T:. (1991). HEMATOLOGICAL STUDIES ON NATURALLY OCCURRING SUBSTANCES. VI. EFFECTS OF AN ANIMAL CRUDE DRUG "CHAN SU" (BUFONIS VENENUM) ON BLOOD COAGULATIN, PLATELET AGGREGATION, FIBRINOLYSIS SYSTEM AND CYTOTOXICITY.. 39(8)

Citation Details

Title	HEMATOLOGICAL STUDIES ON NATURALLY OCCURRING SUBSTANCES. VI. EFFECTS OF AN ANIMAL CRUDE DRUG "CHAN SU" (BUFONIS VENENUM) ON BLOOD COAGULATIN, PLATELET AGGREGATION, FIBRINOLYSIS SYSTEM AND CYTOTOXICITY.
Authors	WANG,JD: NARUI,T: TAKATSUKI,S: HASHIMOTO,T: KOBAYASHI,F: EKIMOTO,H: ABUKI,H: NIJIMA,K: OKUYAMA,T:
Year	1991
Volume	39
Issue	8

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (1)

Bufo bufo-gargorizans (BUFONIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CARDIOTONIC ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
2	DIURETIC ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
3	ANALGESIC ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
4	ANTITUMOR ACTIVITY	MEDICINAL FOLKLORE REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	None
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDQUANTITATIVE DATA	BUFALIN	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BUFALIN	ACTIVE
9	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN	INACTIVE
10	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN	INACTIVE
11	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN	ACTIVE
12	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATA	CINOBUFAGIN	None
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINOBUFAGIN	ACTIVE
14	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN	INACTIVE
15	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN	INACTIVE
16	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN	ACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDQUANTITATIVE DATA	RESIBUFOGENIN	None
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RESIBUFOGENIN	ACTIVE
19	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN	INACTIVE
20	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN	INACTIVE
21	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN	INACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDQUANTITATIVE DATA	GAMABUFOTALIN	None
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GAMABUFOTALIN	ACTIVE
24	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GAMABUFOTALIN	INACTIVE
25	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAMABUFOTALIN	INACTIVE
26	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GAMABUFOTALIN	INACTIVE
27	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDQUANTITATIVE DATA	HELLIBRIGENIN	None
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HELLIBRIGENIN	ACTIVE
29	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HELLIBRIGENIN	INACTIVE
30	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELLIBRIGENIN	INACTIVE
31	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HELLIBRIGENIN	ACTIVE
32	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDQUANTITATIVE DATA	TELOCINOBUFAGIN	None
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TELOCINOBUFAGIN	ACTIVE
34	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TELOCINOBUFAGIN	INACTIVE
35	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TELOCINOBUFAGIN	INACTIVE
36	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TELOCINOBUFAGIN	INACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDQUANTITATIVE DATA	CINOBUFAGIN,DEACETYL:	None
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINOBUFAGIN,DEACETYL:	ACTIVE
39	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL:	INACTIVE
40	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL:	INACTIVE
41	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL:	ACTIVE
42	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDQUANTITATIVE DATA	BUFOTALIN	None
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BUFOTALIN	ACTIVE
44	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN	INACTIVE
45	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN	INACTIVE
46	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN	INACTIVE
47	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDQUANTITATIVE DATA	CINOBUFOTALIN	None
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINOBUFOTALIN	ACTIVE
49	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFOTALIN	INACTIVE
50	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFOTALIN	INACTIVE
51	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFOTALIN	INACTIVE
52	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EPINEPHRINE	None
53	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EPINEPHRINE,EPI:	None

Citation 38664

Citation Details

Summary

Organisms and Their Experiments (1)

Bufo bufo-gargorizans (BUFONIDAE)

Show SPARQL Queries (1)

Query 1